New targets and therapies for gastrointestinal stromal tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New targets and therapies for gastrointestinal stromal tumors

Published:2017-11-20 Issue:12 Volume:17 Page:1117-1129
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Wozniak Agnieszka¹^ORCID,Gebreyohannes Yemarshet K.¹,Debiec-Rychter Maria²,Schöffski Patrick¹³

Affiliation:

1. Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium

2. Department of Human Genetics, KU Leuven, Leuven, Belgium

3. Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2017.1400386

Reference130 articles.

1. Gastrointestinal stromal tumour

2. NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

3. Tumor Genotype Is an Independent Prognostic Factor in Primary Gastrointestinal Stromal Tumors of Gastric Origin: A European Multicenter Analysis Based on ConticaGIST

4. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

5. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a Human Gastrointestinal Stromal Tumor Cell Line Established by SV40LT-Mediated Immortalization;International Journal of Molecular Sciences;2023-09-04

2. Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential;Molecular Oncology;2023-09-03

3. Advances in Drug Therapy for Gastrointestinal Stromal Tumour;Current Medicinal Chemistry;2023-05-05

4. Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors;Frontiers in Oncology;2022-09-06

5. Aurora kinase A (AURKA) promotes the progression and imatinib resistance of advanced gastrointestinal stromal tumors;Cancer Cell International;2021-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3